DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Takahashi H, Nomiyama T, Terawaki Y. et al
Combined treatment with DPP-4 inhibitor linagliptin and SGLT-2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice.
Biochemistry and Biophysics Reports 2019;
18: 100640 . doi:10.1016/j.bbrep.2019.100640
We do not assume any responsibility for the contents of the web pages of other providers.